Remove 3D Remove Biotech Remove Innovation
article thumbnail

The Week’s 10 Biggest Funding Rounds: Another Big Week For Biotech And AI

Crunchbase News

Biotech and AI had another strong week, as the sectors saw two big nine-figure rounds each — including one for $370 million in biotech. Candid Therapeutics , $370M, biotech: Every week there’s a big biotech raise — and this week there’s one that’s really big. Check out last week’s biggest funding rounds here.

Biotech 73
article thumbnail

The Week’s 10 Biggest Funding Rounds: Xcimer Energy Leads The Way As Big Rounds Dry Up

Crunchbase News

tied) Prolific Machines , $55M, biotech: Unlike in previous weeks, there was no huge biotech round. tied) Restor3d , $55M, 3D technology: Restor3d, a North Carolina-based maker of 3D printed personalized orthopedic implants, locked up a $70 million financing — even as investors continue to cool on 3D tech startups.

Energy 114
article thumbnail

Will enterprises soon keep their best gen AI use cases under wraps?

CIO

Similarly, clothing brand Under Armour recently produced an ad that used AI-generated 3D models of the British boxer Anthony Joshua, based on videos they took of him in the past. The victors may not be the greatest innovators, but they’ll be the best at protecting their innovations.

article thumbnail

Lucky 13: A Baker’s Dozen Join Unicorn List In July

Crunchbase News

Healthcare/biotech companies took the lead with three companies that joined the board from this sector. Google Ventures , US Innovative Technology Fund , General Catalyst , Founders Fund , Caffeinated Capital and angel investor Elad Gil each have two portfolio companies across this cohort. Who invested?

Biotech 97
article thumbnail

Daily Crunch: Citing ‘uncertain mortgage market,’ Better.com rolls out employee buyout plan

TechCrunch

Printing me softly with his song : Mostly known for its battery packs, Anker launches a Kickstarter campaign for its first 3D printer. 6 questions investors should ask when evaluating psychedelic biotech companies. 6 questions investors should ask when evaluating psychedelic biotech companies. You can sign up here.).

Marketing 235
article thumbnail

Charm Therapeutics applies AI to complex protein interactions, locking down $50M A round

TechCrunch

“That’s really where we have innovated: we have built DragonFold, which is the first protein-ligand co-folding algorithm,” said Laskh Aithani, CEO and co-founder of Charm Therapeutics. “Designing drugs that bind to the disease-causing protein of interest very tightly and selectively (i.e.,

article thumbnail

You could be Wasted and not even know it

TechCrunch

Don’t worry, there are still tensions to pay attention to in today’s market, but this episode was refreshingly about innovation, and a shifting to this new normal we keep hearing about.

3D 190